Helixmith Co., Ltd.

République de Corée


Commandez votre montre hebdomadaire Helixmith Co., Ltd.
Quantité totale PI 57
Rang # Quantité totale PI 24 460
Note d'activité PI 2,5/5.0    39
Rang # Activité PI 19 119
Symbole boursier 084990 (kosdaq)
ISIN KR7084990001
Capitalisation 140.90001B  (KRW)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

21 3
6 1
23 3
0
 
Dernier brevet 2025 - Liquid formulation pharmaceutica...
Premier brevet 2003 - Highly efficient eukaryotic expr...
Dernière marque 2020 - HELIXMITH
Première marque 2018 - ENGENSIS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Composition for preventing or alleviating obesity and reducing body fat, comprising herbal medici...
Invention Composition for improving skin condition. The present invention relates to a composition for impr...
2023 Invention Aav vector optimized for intrathecal administration into which hepatocyte growth factor gene is i...
Invention Composition for preventing or treating sarcopenia by using insulin-like growth factor-1 isoform. ...
2022 Invention Crude drug composition for preventing or treating respiratory diseases. The present disclosure r...
Invention Liquid formulation pharmaceutical composition comprising plasmid dna. The present invention rela...
Invention Liquid formulation pharmaceutical composition comprising plasmid dna. The present invention relat...
Invention Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs. The ...
Invention Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathy. The pr...
Invention Pharmaceutical composition for preventing or treating charcot-marie-tooth disease. The present in...
Invention Herbal composition for preventing or treating benign prostatic hyperplasia disease. The present ...
2021 Invention Composition for preventing or treating inflammatory bowel disease, containing complex herbal medi...
2020 Invention Composition for preventing or treating hypertension. The present invention relates to a compositi...
P/S Pharmaceutical preparations for health care; crude medicines; pharmaceutical preparations extrac...
P/S Pharmaceutical preparations for health care for treating neurological diseases, muscular diseases...
Invention Composition for preventing or treating inflammatory bowel disease comprising extracts of complex ...
Invention Chimeric antigen receptor comprising anti c-met antibody or antigen binding fragment thereof, and...
Invention Gene therapy for diabetic neuropathy using an hgf isoform. The present invention relates to a ph...
Invention Pharmaceutical composition comprising mixture extract of coptis rhizome and schizonepeta tenuifol...
Invention Pharmaceutical composition comprising mixture extract of coptis deltoidea and schizonepeta tenuif...
2019 Invention Biomarkers for predicting prognosis of kidney disease. A kit for diagnosing a renal disease or p...
Invention Composition for preventing or treating metabolic bone diseases or menopausal symptoms. The prese...
Invention Composition for preventing or treating metabolic bone disease or menopausal symptoms. The present...
Invention Composition for preventing or treating metabolic bone diseases or menopausal symptoms. The presen...
Invention Anti-c-met antibody showing enhanced stability or antigen-binding fragments thereof. The present ...
Invention Anti-l1cam antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising ...
Invention Lyophilized pharmaceutical compositions for naked dna gene therapy. The present invention provide...
Invention Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs. The p...
Invention Treatment of neuropathy with dna constructs expressing igf-1 isoforms. The present invention rela...
Invention Treatment of neuropathic pain associated with chemotherapy-induced peripheral neuropathy. The pre...
Invention Herbal composition for treatment of attention deficit hyperactivity disorder. Disclosed are a pha...
Invention Herbal composition for treatment of attention deficit hyperactivity disorder. The present inventi...
Invention Gene therapy for diabetic neuropathy using an hgf isoform. The present invention relates to a pha...
Invention Crude drug composition for preventing or treating respiratory diseases. The present disclosure re...
Invention Crude drug composition for preventing or treating respiratory diseases. The present invention rel...
P/S Crude medicines; reagents for use in veterinary genetic testing; chemical preparations for pharm...
2018 Invention Adeno-associated virus (aav) vector having hybrid hgf gene introduced thereto. The present invent...
P/S reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmac...
Invention Treatment of neuropathy with dna construct expressing hgf isoforms with reduced interference from...
P/S Genetic treatment preparations, namely biological preparations for use in gene therapy for the tr...
P/S Genetic treatment preparations; reagents for use in veterinary genetic testing; reagents for use...
P/S Chemical reagents for use in veterinary genetic testing; reagents for use in medical genetic test...
2017 Invention Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepa...
Invention Methods of treatment using anti-c-met antibodies. The present disclosure provides a pharmaceutica...
2016 Invention Anti-sialyl tn chimeric antigen receptors. The invention provides improved compositions for adopt...